PMDA — authorised 25 March 2020
- Marketing authorisation holder: Nobelpharma Co., Ltd
- Status: approved
PMDA authorised Melatol on 25 March 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 25 March 2020.
Nobelpharma Co., Ltd holds the Japanese marketing authorisation.